🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Arabinda Das

Endeavor Health

ORCID: 0000-0002-0086-4760

Also affiliated with Medical University of South Carolina, University of Chicago, Endeavor Charter School, MUSC Hollings Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Tamoxifen is a candidate first‐in‐class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells—Unrecognized players in tumorigenesis.

52 citations

Ping Lü, Christian M. Jones, S Chiodini, Deborah Hurley, Arabinda Das +4 more

12 citations

David Cachia, Sunil J. Patel, Arabinda Das, Bruce Frankel

0 citations

David Cachia, Sunil J. Patel, Arabinda Das, Bruce Frankel

12 citations

Arabinda Das, Supriti Samantaray, Denise Matzelle, Mollie Capone, Gerald Wallace +7 more

8 citations

Nicole Trager, Jonathan T. Butler, Arabinda Das, Vandana Zaman, Naren L. Banik +1 more

0 citations

Brian F. Saway, Rohan Jha, Matheus P. Pereira, Neel H. Mehta, Arabinda Das +4 more